Cravatex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the unaudited financial results for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cravatex Ltd has informed BSE that its Board of Directors will meet on Friday, 14 November 2025. The meeting will, among other matters, consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2025 (Q2 FY26 / H1 FY26). The intimation is filed under Regulation 29(1) of the SEBI Listing Obligations and Disclosure Requirements. No financial figures or business details have been disclosed in this filing — it is purely a notice of the upcoming board meeting.
This is a routine regulatory intimation and not a result announcement itself. Investors should watch for the actual Q2/H1 FY26 results expected to be released after 14 November 2025, which may influence short-term stock movement depending on performance versus expectations.